Prolong Pharmaceuticals
Company Details
Status: Private
Employees: 101-250
Location:
Monmouth Junction, New Jersey, United States
Type:
sample
Technology:
sample
About: Headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC is developing products to treat several diseases and their debilitating comorbidities which cause reduced quality of life, increased medical costs and significant mortality. Comorbidities are a common consequence of sickle cell disease, chemotherapy, atherosclerosis, diabetes and many other diseases.
- The company's lead product, SANGUINATE™, is focused on treating the comorbidities of sickle cell disease and hemorrhagic stroke
- Prolong has a long-acting 3rd generation biologic in clinical development for the treatment of anemia, a comorbidity common with chronic kidney disease and cancer chemotherapy
- Other products are also in development for comorbidities that result from diseases such as cardiovascular disorders and cancer
___________
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Prolong Pharmaceuticals | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.